According to a recent annual report, there are close to 20,000 Risperdal lawsuits pending against manufacturers, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals. The report stated that Johnson & Johnson along with Janssen is involved in many...
For years, Johnson & Johnson’s anticoagulant, Xarelto was the market leader of blood thinners. Now, Eliquis, marketed by Bristol-Myers Squibb and Pfizer is leading Xarelto based upon prescription data. Eliquis brought in 667,000 prescriptions last September while...
The dangerous blood thinner, Xarelto headed for a new use. Manufacturer, Janssen announced they would be stopping their COMPASS trial a year early. This trial is part of their Explorer research program to expand Xarelto to 10 more label uses. COMPASS trial was...
If you are at risk for a stroke or heart attack, a doctor may prescribe a blood thinner such as Xarelto or Eliquis. These drugs are heralded as life-saving medications. But, they also bring a fatal side effect, too, and there is no way to reverse it. Why Would I Need...
Recent Comments